Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection
Statistics in Medicine · 2025
DOI: 10.1002/sim.70102 ↗At a glance
Journal article in Statistics in Medicine, 2025. Written by Sumeet Kalia and 8 co-authors. Institution: Department of Statistics, University of Manitoba, Winnipeg, Canada. Major MEDLINE topics: Urinary Tract Infections, Sodium-Glucose Transporter 2 Inhibitors, Models, Statistical. Cited 2 times so far (Crossref); 69 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Natural Sciences and Engineering Research Council of Canada.
Abstract (original language)
Treatment‐confounder feedback is present in time‐to‐recurrent or longitudinal event analysis when time‐dependent confounders are themselves influenced by previous treatments. Conventional models produce misleading statistical inference of causal effects due to conditioning on these factors on the causal pathway. Marginal structural models are often applied to quantify the causal treatment effect, estimated using longitudinal weights that mimic the randomization procedure by balancing the covariate distributions across the treatment groups. The weights are usually constructed in discrete time intervals, which is appropriate if the follow‐up visits are scheduled and regular. However, in primary care, visit times can be irregular and informative, and the treatment history consists of duration and doses. This can be modeled through a continuous‐time marked point process. We constructed a continuous‐time marginal structural model to estimate the effect of cumulative exposure to Sodium‐Glucose co‐Transporters 2 Inhibitor (SGLT‐2i) medications on time‐to‐recurrent urinary tract infection (UTI). We used a cohort of type II diabetes patients with chronic kidney disease and constructed a marked point process that characterized the recurrent flare episodes of primary care visits (i.e., point process) with marks for the multinominal dose (none, low, high) of SGLT‐2i medications and recurrent episodes of UTI. We applied the stabilized and optimal treatment weights to estimate the hypothesized causal effect. Our results are concordant with earlier findings in which the recurrent episodes of UTI did not increase when patients were prescribed low dose or high dose of SGLT‐2i medications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Statistics, University of Manitoba, Winnipeg, Canada.
- Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
- School of Medicine, University of St Andrews, St Andrews, UK.
ORCID profiles: Sumeet Kalia, Olli Saarela, Christopher Meaney
Funding
- Natural Sciences and Engineering Research Council of Canada
Cite
APA
Kalia, S., Saarela, O., Chen, T., O'Neill, B., Meaney, C., Moineddin, R., Aliarzadeh, B., Sullivan, F., & Greiver, M. (2025). Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection. Statistics in Medicine. https://doi.org/10.1002/sim.70102
Vancouver
Kalia S, Saarela O, Chen T, O'Neill B, Meaney C, Moineddin R, et al. Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection. Statistics in Medicine. 2025. doi:10.1002/sim.70102
BibTeX
@article{Kalia2025,
author = {Kalia, Sumeet and Saarela, Olli and Chen, Tao and O'Neill, Braden and Meaney, Christopher and Moineddin, Rahim and Aliarzadeh, Babak and Sullivan, Frank and Greiver, Michelle},
title = {Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70102}
}
EUVIMED